CTA
NTUS

Carillon Tower Advisers’s Natus Medical Inc NTUS Stock Holding History

Carillon Tower Advisers’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,206,572
Closed -$41.1M – 477
2018
Q4 		$41.1M Hold
1,206,572
– – 0.35% 94
2018
Q3 		$43M Hold
1,206,572
– – 0.31% 126
2018
Q2 		$41.6M Buy
+1,206,572
New +$42.3M 0.33% 107

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return
SV
Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Carillon Tower Advisers's NTUS Position: Q1 2019 in Review

Carillon Tower Advisers sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 1,206,572 shares — an estimated $41.1M sold.

Carillon Tower Advisers first reported a position in NTUS in Q2 2018 and held it in 3 quarters. The position peaked at $43M in Q3 2018. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • Carillon Tower Advisers reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
  • Carillon Tower Advisers sold 1,206,572 Natus Medical Inc shares in Q1 2019, an estimated $41.1M.
  • Carillon Tower Advisers first reported a position in Natus Medical Inc in Q2 2018 and held it in 3 quarters.
  • Carillon Tower Advisers's Natus Medical Inc position peaked at $43M in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Carillon Tower Advisers's 13F filing for Q1 2019, filed 3 May 2019.